TriangleFOR PATIENTS · SOURCE READING
Other drug therapy
Source: Myeloproliferative Neoplasms Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: May 12, 2025 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.
Context: Treatment Option Overview / The following types of treatment are used:
Prednisone and danazol are drugs that may be used to treat anemia in patients with primary myelofibrosis.
Source links and citations
Anagrelide therapy is used to reduce the risk of blood clots in patients who have too many platelets in their blood. Low-dose aspirin may also be used to reduce the risk of blood clots.
Source links and citations
Thalidomide, lenalidomide, and pomalidomide are drugs that prevent blood vessels from growing into areas of tumor cells.
Source links and citations
Erythropoietic growth factors are used to stimulate the bone marrow to make red blood cells.
Source links and citations
Learn more at Drugs Approved for Myeloproliferative Neoplasms.
Source links and citations
Preserved source evidence · Independent clinical review pending · Not medical advice